Acd-a Solution
NDC Package 0942-0641-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Acd-a (anticoagulant citrate dextrose solution formula a) solution is classified as a

administered via intravenous route. This formulation utilizes a solution delivery system. Marketed by Fenwal, Inc., this product is identified by NDC 0942-0641 and is authorized under FDA application BN160918.

Identification & Billing

NDC Package Code
0942-0641-04
Package Description
1000 mL in 1 BAG
Product Code
0942-0641
11-Digit Billing Format
00942064104
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
1000 ML

Clinical Specifications

Proprietary Name
Acd-a
Non-Proprietary Name
Anticoagulant Citrate Dextrose Solution Formula A
Substance Name
Anhydrous Citric Acid; Dextrose Monohydrate; Sodium Citrate, Unspecified Form
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Fenwal, Inc.
Product Type
Human Prescription Drug
FDA Application #
BN160918
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-01-2007
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0942-0641). Click a package code to view its specific billing and regulatory data.

0942-0641-03
500 mL in 1 BAG

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0942-0641-04 identifies a specific commercial package of 1000 ml in 1 bag of Acd-a, a human prescription drug labeled by Fenwal, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 1000 billable units per package. This solution is formulated for intravenous use and contains anhydrous citric acid; dextrose monohydrate; sodium citrate, unspecified form as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fenwal, Inc. on March 01, 2007. The current certification is valid through December 31, 2026.

How is this Fenwal, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00942064104. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0942-0641-04
11-Digit CMS (5-4-2)
00942-0641-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.